Clinical Trial Update: Multidrug Resistant Shigella Infection in Bangladesh

View source ↗

Summary

An update on a clinical trial in Bangladesh studying treatments for multidrug-resistant Shigella infection. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shigellosis

Snippet

Sponsor: University of Virginia | Conditions: Diarrhea, Shigella | Status: UNKNOWN